Filipčić, Igor http://orcid.org/0000-0002-3283-8786
Šimunović Filipčić, Ivona http://orcid.org/0000-0002-3265-0046
Sučić, Strahimir
Milovac, Željko
Gereš, Natko
Matić, Katarina
Čelić-Ružić, Mirela
Zečević Penić, Sandra
Orgulan, Ivana
Požgaj, Vladimir
Bajić, Žarko http://orcid.org/0000-0002-7983-6892
Article History
Received: 29 January 2020
Accepted: 15 May 2020
First Online: 24 May 2020
Compliance with ethical standards
:
: IF has received equipment for research from Brainsway. He has served on a scientific advisory board for Janssen and Brainsway and received personal fee from Eli Lilly and Company, Lundbeck, Pfizer, TEVA, Belupo. For the remaining authors, no conflicts of interest were declared.
: The study protocol was approved by the Ethics committee of the Psychiatric Hospital “Sveti Ivan”, Zagreb, Croatia, and all participants verified their informed consent by signing the Consent form. We have not obtained an independent Ethics committee approval. This pilot study was part of the main randomized controlled trial whose protocol was registered at ClinicalTrials.gov (NCT03718013) on October 24, 2018. The study was conducted in compliance with the World Health Organization Declaration of Helsinki of 1975, as revised in 2013 [CitationRef removed].